Physician profile
Benjamin Mcintyre
NPI 1407067705
$11,206.01
in general payments reported to CMS, 2019-2025
31 companies · $1,333 in 2025
The $1,333 reported for 2025 was more than what 77% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,793 · 2020: $500 · 2021: $1,186 · 2022: $1,957 · 2023: $1,891 · 2024: $2,546 · 2025: $1,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,570 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,570.25 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $1,689.94 | 2024-2025 | |
| Stryker Corporation | $1,123.41 | 2019-2025 | Na, Delta, Vsp System, Vsp Cranial |
| Mentor Worldwide LLC | $1,118.84 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Tela Bio, INC. | $996.02 | 2022-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Kerecis Limited | $936.74 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Abbvie INC. | $689.03 | 2023-2025 | |
| Kls-Martin L.P. | $649.06 | 2019-2024 | |
| Depuy Synthes Sales INC. | $520.15 | 2019-2024 | Na |
| Sientra, INC. | $438.84 | 2019-2021 | |
| Access Pro Medical, LLC | $435.27 | 2022-2023 | Matriderm |
| Integra Lifesciences Corporation | $378.23 | 2022-2023 | Durasorb Monofilament Mesh, Tenoglide |
| Baxter Healthcare | $343.84 | 2019-2022 | |
| Allergan, INC. | $337.96 | 2019-2022 | |
| Davol INC. | $279.10 | 2024-2025 | Phasix Mesh |
| Axogen | $255.65 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $146.08 | 2024 | Novosorb Btm |
| Revance Therapeutics, INC. | $139.51 | 2025 | Daxxify |
| Amgen INC. | $137.32 | 2019-2020 | |
| Dilon Technologies, INC. | $118.23 | 2025 | Hemoblast Bellows |
| Puma Biotechnology, INC. | $84.29 | 2019-2020 | |
| Checkpoint Surgical, INC | $76.72 | 2023 | Checkpoint Stimulators |
| Musculoskeletal Transplant Foundation INC. | $68.25 | 2024 | |
| Kci USA, INC. | $58.47 | 2019-2023 | Prevena, V.A.C. Dermatac, Activ.A.C. |
| Acera Surgical, INC. | $52.99 | 2019 | |
| Zimmer Biomet Holdings, INC. | $36.80 | 2019 | |
| Somavac Medical Solutions, INC. | $25.72 | 2021 | |
| Sanara Medtech INC. | $18.08 | 2022 | |
| Tesaro, INC. | $14.87 | 2019 | |
| Tei Biosciences INC | $14.40 | 2019 | |
| Pfizer INC. | $12.34 | 2019 | |
| Medela LLC | $9.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Mcintyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.